PapersPMID:20605696
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT · 8 weeks
- Dose studied, every finding
- beverage 4 cups/day (4 tea bags steeped in 4 cups, about 110 mg EGCG per cup) or 2 extract capsules/day (about 230 mg EGCG each), each versus 4 cups water/day
- Population, every finding
- Obese adults with metabolic syndrome (NCEP ATP III), randomised in age- and gender-matched trios to green tea beverage, green tea extract or water; 29 analysed in 11 beverage-vs-no-treatment and 7 extract-vs-no-treatment pairs; beverage and extract groups pooled in this sentence
No finding here moved its endpoint.
What did not
How to read these marks →“Plasma concentrations of adiponectin, CRP, IL-6, IL-1β, sVCAM-1, sICAM-1, leptin and leptin: adiponectin ratio were not significantly affected by green tea beverage or extract supplementation for eight weeks versus age and gender-matched no treatment group (Table 2).”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Obese adults with metabolic syndrome (NCEP ATP III), University of Oklahoma; decaffeinated green tea beverage (4 cups/day) or green tea extract capsules vs no treatment (4 cups water/day), 8 weeks, single-blind age- and gender-matched trios
- Participants
- 35
- Comparator
- no treatment
- Duration
- 56 days
- Endpoints measured
- 23
- Declined
- the intervention held more than the compound